|
CCDC93 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.537800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.351600E-01 |
| Normal-vs-Stage2 |
8.641000E-01 |
| Normal-vs-Stage3 |
1.133780E-01 |
| Normal-vs-Stage4 |
5.553800E-01 |
| Stage1-vs-Stage2 |
4.128200E-01 |
| Stage1-vs-Stage3 |
4.230000E-01 |
| Stage1-vs-Stage4 |
9.635000E-01 |
| Stage2-vs-Stage3 |
2.342400E-01 |
| Stage2-vs-Stage4 |
6.065600E-01 |
| Stage3-vs-Stage4 |
6.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.847000E-01 |
| Normal-vs-AfricanAmerican |
8.596400E-01 |
| Normal-vs-Asian |
8.549700E-02 |
| Caucasian-vs-AfricanAmerican |
3.104800E-01 |
| Caucasian-vs-Asian |
4.480400E-01 |
| AfricanAmerican-vs-Asian |
3.211800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.212100E-02 |
| Normal-vs-Female |
1.418400E-01 |
| Male-vs-Female |
4.081700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.938400E-01 |
| Normal-vs-Extreme_Weight |
4.323400E-03 |
| Normal-vs-Obese |
7.885800E-01 |
| Normal-vs-Extreme_Obese |
9.328200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.504400E-01 |
| Normal_Weight-vs-Obese |
2.442400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.418200E-01 |
| Extreme_Weight-vs-Obese |
6.415600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.577200E-01 |
| Obese-vs-Extreme_Obese |
9.408000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.779800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.343600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.307800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.287600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.729600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.123010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.319770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.219210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.057400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.858200E-01 |
| Normal-VS-Type2 PRCC |
7.426200E-02 |
| Normal-VS-KIRP CIMP |
6.566000E-01 |
| Normal-VS-Unclassified PRCC |
3.979400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.314150E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.614200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.604800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.068000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.766000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.189000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.000900E-03 |
| Normal-vs-N1 |
7.585400E-01 |
| Normal-vs-N2 |
5.857200E-01 |
| N0-vs-N1 |
8.461900E-02 |
| N0-vs-N2 |
1.828170E-01 |
| N1-vs-N2 |
8.939600E-01 |
|
|
